Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you stop taking Wegovy, the appetite-suppressing effects of semaglutide gradually wear off as the medicine clears your system over several weeks. Most people find hunger returns, often to levels higher than they experienced before starting treatment, and some weight regain is common. This is not a personal failing — it reflects how the medicine works, and how the body responds once that signal is gone. Because Wegovy is a prescription-only medicine, any decision about stopping, pausing or changing treatment should be made with your prescriber rather than unilaterally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It comes back. This is one of the most consistent findings in semaglutide research, and the NHS medicines page for semaglutide is candid about it: the medicine reduces hunger while you take it, and those effects are tied to the drug being present. Semaglutide's half-life is approximately seven days. That means, after your final injection, concentrations in your bloodstream roughly halve each week. By weeks four to six, the clinical effect on appetite is largely gone.
What many people are not prepared for is the intensity of the hunger that returns. During treatment, GLP-1 receptors in the brain and gut are regularly stimulated by semaglutide, slowing gastric emptying and signalling fullness. Once stimulation stops, those systems can overshoot in the other direction. Appetite may feel stronger than it did before you started. This is a physiological rebound, not a sign that the treatment failed.
The practical check worth doing in the days after stopping: weigh yourself at the same time each morning, in the same clothes (or without), before eating. A week-on-week record, rather than daily fluctuations, is what actually tells you something useful. That habit takes under a minute and removes a lot of the noise.
Faster than most people hope, though the timeline varies considerably. The STEP 1 extension study tracked participants for a year after they stopped semaglutide 2.4mg. On average, participants had regained about two-thirds of their original weight loss within 12 months of stopping, alongside a partial return of cardiometabolic risk markers. The researchers published these findings in the New England Journal of Medicine, and they have shaped how prescribers now think about stopping decisions.
The speed of regain depends heavily on what is or is not in place when someone stops. People who have made lasting changes to eating patterns and who remain physically active regain less, and more slowly, than those who return to previous habits once appetite reasserts itself. That is not a moral judgment, it simply means the behavioural work done during treatment acts as a partial buffer. A reduced-calorie diet and consistent activity still matter even when the pharmacological support is withdrawn.
It is also worth knowing that this pattern is not unique to Wegovy. You can read more about what happens when you come off semaglutide more broadly, including how this compares across the different products that contain it.
There is no official clinical protocol that requires a tapering schedule before stopping Wegovy, in the way that some other medicines require a gradual reduction. Semaglutide's long half-life means the body experiences a natural taper simply by virtue of the drug's pharmacokinetics. That said, abruptly stopping at a higher dose versus a lower dose will produce different experiences, because a higher dose means more semaglutide in your system when you take the last injection.
Your prescriber may suggest stepping down through lower doses over a month or two if your circumstances allow it. This is partly about managing the subjective experience of returning appetite and partly about giving you time to reinforce the habits built during treatment. It is a conversation worth having before you stop, not after. If you are thinking about stopping because of side effects rather than choice, what happens when you stop Wegovy covers that scenario specifically.
Pregnancy is a separate and important reason that some people need to stop: Wegovy is not recommended during pregnancy, and if you are planning to conceive, you need to stop with adequate notice before trying. The page on getting pregnant on Wegovy explains the recommended washout period and what to discuss with your prescriber.
A conversation with your prescriber before your final injection is the single most useful thing you can do. At nume, sorry, at our pharmacy, prescribers do not just approve repeat orders; they review the full clinical picture each time, including whether continuing treatment still makes sense for you. That review is the moment to raise a planned stop.
After stopping, the things with the strongest evidence behind them are: maintaining a calorie-aware diet without extreme restriction (which tends to drive compensatory hunger), prioritising protein at each meal to support satiety, and keeping some form of resistance or weight-bearing activity going. None of this is novel advice, but it lands differently when you understand what happens when you take Wegovy and what you are actually working against once that mechanism is removed.
Some people stop Wegovy because they want to trial a period without it after significant weight loss, and later return to treatment. There is no clinical reason you cannot restart, subject to a fresh assessment, though it is sensible to check how long before Wegovy expires if you have pens in storage that you plan to use again. If you are weighing up what treatment options remain available, exploring the weight-loss treatment landscape is a reasonable starting point. And if cost was a factor in your stopping decision, understanding the full picture of what Wegovy costs through a regulated private service may change the calculation.
If you have questions about where you stand or what the right next step is, a conversation with a prescriber is the clearest path forward. Speak to our prescribers through a free consultation, there is no obligation, and every assessment is done by a named clinician, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.